Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer

Faculty of Medicine

Assiut University

Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer

Research Authors
Samia A. Ali, Hanan G. Mostafa, Mohamed Alaa-eldeen H. Mohamed, Noha A. Abo-elala
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
Kasr Al-Aini J. of Clinical Oncology and Nuclear Medicine
Research Member
Prof.Hanan Gamal El-Din Moustafa Morsy
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015
Research_Pages
NULL
Research Abstract

NULL